Articles published by Crescita Therapeutics
Crescita Reports Second Quarter 2024 Results
August 07, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
July 22, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
July 19, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
July 17, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
June 26, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita to Acquire Strategic Assets of Occy Laboratory
June 20, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 06, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Reports First Quarter 2024 Results
May 08, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Reports Q4 and Fiscal 2023 Results
March 13, 2024
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
August 29, 2023
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Reports Second Quarter 2023 Results
August 09, 2023
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 21, 2023
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
May 12, 2022
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Reports First Quarter 2022 Results
May 11, 2022
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
April 21, 2022
From
Crescita Therapeutics
Via
Business Wire
Tickers
CRRTF
OTC
TSX:CTX
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid
December 15, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®
December 13, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member
November 11, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC
September 09, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Reports Second Quarter 2021 Results and Provides Corporate Update
August 11, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
TSX:CTX
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
May 12, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Crescita Reports First Quarter 2021 Results
May 11, 2021
From
Crescita Therapeutics
Via
Business Wire
Tickers
OTC
TSX:CTX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.